BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37267155)

  • 1. Bilaterality, not multifocality, is an independent risk factor for recurrence in low-risk papillary thyroid cancer.
    Rodriguez Schaap PM; Lin JF; Metman MJH; Dreijerink KMA; Links TP; Bonjer HJ; Nieveen van Dijkum EJM; Dickhoff C; Kruijff S; Engelsman AF
    J Natl Cancer Inst; 2023 Sep; 115(9):1071-1076. PubMed ID: 37267155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma.
    Kim HJ; Sohn SY; Jang HW; Kim SW; Chung JH
    World J Surg; 2013 Feb; 37(2):376-84. PubMed ID: 23135422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological multifocality is not a prognosis factor of papillary thyroid carcinoma: a single-center, retrospective study.
    Omi Y; Haniu K; Kamio H; Fujimoto M; Yoshida Y; Horiuchi K; Okamoto T
    World J Surg Oncol; 2022 Dec; 20(1):394. PubMed ID: 36510206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of tumor size and focality with recurrence/persistence in papillary thyroid cancer patients treated with total thyroidectomy along with radioactive-iodine ablation and TSH suppression.
    Khan M; Syed AA; Khan AI; Hussain SR; Urooj N
    Updates Surg; 2018 Mar; 70(1):121-127. PubMed ID: 28550398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of tumor multifocality in papillary thyroid carcinoma and its relationship with primary tumor size: a retrospective study of 2,309 consecutive patients.
    Kim KJ; Kim SM; Lee YS; Chung WY; Chang HS; Park CS
    Ann Surg Oncol; 2015 Jan; 22(1):125-31. PubMed ID: 25092159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral multifocality is an independent predictor of patients' outcome in Middle Eastern papillary thyroid carcinoma.
    Parvathareddy SK; Siraj AK; Annaiyappanaidu P; Siraj N; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
    Front Endocrinol (Lausanne); 2022; 13():1060301. PubMed ID: 36686467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Factors for Bilaterality in Papillary Thyroid Carcinoma with Tumor Size <4 cm.
    Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
    Thyroid; 2017 Feb; 27(2):207-214. PubMed ID: 27750022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer.
    Qu N; Zhang L; Wu WL; Ji QH; Lu ZW; Zhu YX; Lin DZ
    Tumour Biol; 2016 Jul; 37(7):8783-9. PubMed ID: 26743781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Tumor Multifocality in Pediatric Papillary Thyroid Carcinoma: A Real-Life Multicentric Study.
    Xu Y; Shi L; Wu J; Li H; Wang Y; Liu B
    Otolaryngol Head Neck Surg; 2023 Dec; 169(6):1606-1614. PubMed ID: 37222185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifocality of papillary thyroid carcinoma as a risk factor for disease recurrence.
    Choi WR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2019 Jul; 94():106-110. PubMed ID: 31178204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A UK based two-centre review of multifocality and its role in the treatment of papillary thyroid cancer.
    Li LQ; Hey SY; Andreeva D; Tornari C; Sawant R; Harding NE; Adamson R; Hay A; Simo R; Nixon IJ
    Eur J Surg Oncol; 2022 Jan; 48(1):14-20. PubMed ID: 34253424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should multifocality be an indication for completion thyroidectomy in papillary thyroid carcinoma?
    Harries V; Wang LY; McGill M; Xu B; Tuttle RM; Wong RJ; Shaha AR; Shah JP; Ghossein R; Patel SG; Ganly I
    Surgery; 2020 Jan; 167(1):10-17. PubMed ID: 31515125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extent of surgery did not affect recurrence during 7-years follow-up in papillary thyroid cancer sized 1-4 cm: Preliminary results.
    Kim MJ; Lee MC; Lee GH; Choi HS; Cho SW; Kim SJ; Lee KE; Park YJ; Park DJ
    Clin Endocrinol (Oxf); 2017 Jul; 87(1):80-86. PubMed ID: 28338234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The appropriateness of thyroid lobectomy as an initial surgery for preoperatively detected unilateral multifocal papillary carcinoma.
    Albinsaad LS; Kim WW; Lee YM; Sung TY; Chung KW; Hong SJ
    Asian J Surg; 2021 Aug; 44(8):1050-1055. PubMed ID: 33573922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer.
    Wang F; Yu X; Shen X; Zhu G; Huang Y; Liu R; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Wang Y; Liu S; Zhao J; Zhao S; Xing M
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3241-3250. PubMed ID: 28582521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative predictors and prognosis of bilateral multifocal papillary thyroid carcinomas.
    Polat SB; Cakir B; Evranos B; Baser H; Cuhaci N; Aydin C; Ersoy R
    Surg Oncol; 2019 Mar; 28():145-149. PubMed ID: 30851890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of incomplete response to therapy among Filipino patients with papillary thyroid cancer in a tertiary hospital.
    Mendoza ES; Lopez AA; Valdez VA; Cunanan EC; Matawaran BJ; Kho SA; Sero-Gomez MH
    J Endocrinol Invest; 2016 Jan; 39(1):55-62. PubMed ID: 26036600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment.
    Grigsby PW; Reddy RM; Moley JF; Hall BL
    Surgery; 2006 Dec; 140(6):1043-7; discussion 1047-9. PubMed ID: 17188155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is multifocality a risk factor in low-risk papillary thyroid cancer?
    Sapuppo G; Grasso S; Di Benedetto G; Marturano I; Costanzo G; Belfiore A; Pellegriti G
    Endokrynol Pol; 2022; 73(6):928-934. PubMed ID: 36094871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.